Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
5.16 (- 0.08)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Jun 25, 2015
Conatus Announces Initial Baseline Data From Phase 2b POLT-HCV-SVR Clinical Trial of Emricasan Confirming Activity of Relevant Mechanisms and Opportunity for Histological Improvement

Jun 22, 2015
Conatus Pharmaceuticals Appoints Mason M. Yamashita as Vice President, Pharmacovigilance

View all »Events & Presentations

Jun 24, 2015
2nd Annual ROTH Healthcare Day

Jun 23, 2015
JMP Securities 2015 Life Sciences Conference
PDF View Presentation   2.2 MB   Add to Briefcase